🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Opioid Withdrawal

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder NCT06487533n/a2 sites📍 Center City📍 Columbus Spark Biomedical, Inc. · Tests: EmbracePlus Smartwatch, Corti Sensor Cannabis and Opioid Use Disorder NCT05729932Phase 11 site📍 Lexington Shanna Babalonis, PhD · Tests: Inhaled vaporized cannabis, Intransal opioid Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain NCT05555485NA1 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: transcutaneous Auricular neurostimulation - Active, transcutaneous auricular neurostimulation - Sham Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome NCT05937594n/a1 site📍 Hershey Milton S. Hershey Medical Center · Tests: Buccal swab saliva for further genetic testing Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms NCT07079215NA1 site📍 Daegu Nu Eyne Co., Ltd. · Tests: Neurostimulation, Sham stimulation Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal NCT04939623Phase 21 site📍 Calgary University of Calgary · Tests: Probenecid Assessing a Clinically-meaningful Opioid Withdrawal Phenotype NCT05027919Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Hydromorphone, Naloxone + lofexidine pretreatment, Naloxone + placebo pretreatment, Lofexidine Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal NCT05995535Phase 22 sites📍 Baltimore📍 Philadelphia University of Pennsylvania · Tests: LFX/PGB, LFX/PLA-PGB Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder NCT07079826NA1 site📍 Pittsburgh Payel Roy · Tests: Sparrow Link (Active tAN), Sparrow Link (Sham tAN) Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 NCT05834478Phase 36 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Transcutaneous Cervical Vagal Nerve Stimulation, Sham Stimulation, [F-18]Fallypride CEDRN: Opioid Registry NCT07466784n/a1 site📍 Vancouver University of British Columbia A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals NCT07405398NA1 site📍 Wilmington OpiAID · Tests: Train and evaluate the accuracy and reliability of the Strength Band Platform in identifying acute opioid dosing events… Evaluating Buspirone to Treat Opioid Withdrawal NCT05511909Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Buspirone, Lofexidine, Placebo Cerebral Physiology of NOWS NCT07610746NA1 site📍 Indianapolis Indiana University · Tests: FD-NIRS and DCS Ketones for Opioid Craving NCT07128524Phase 21 site📍 Wernersville University of Maryland, Baltimore · Tests: Treatment with Ketone Supplement, Treatment with Placebo Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome NCT07278375n/a22 sites📍 Birmingham📍 Little Rock📍 Wilmington HELP for NOWS Consortium ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain NCT06442566Phase 1, Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Buprenorphine Patch, Placebo, Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS) A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain NCT07874620Phase 22 sites📍 North Canton📍 Houston Adneuris Therapeutics, Inc. · Tests: Cebranopadol, Cebranopadol, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy